(JP4149521) Applying an exogenous chemical (EC) to a plant, comprises: (a) contacting foliage of a plant with the EC; and (b) contacting the same foliage with an aqueous composition, containing a first amphiphilic excipient (E1); in which (i) the weight/weight ratio of E1/EC is between 1:3 and 1:100; (ii) the aqueous composition forms anisotropic aggregates in or on a wax layer; and (iii) operations (a) and (b) are simultaneous, or within 96 hours of each other. (From HU0001454 A2)
(RU2598154) FIELD: food industry.SUBSTANCE: invention relates to production process for kvass beverage. Method involves preparation of recipe components, mashing dry kvass with hot water and settling three times with separation of liquid phase from pulp to produce kvass wort, adding 25 % of sugar formulation quantity in the form of white syrup, bakery yeast fermentation, blending with the remaining sugar in the form of white syrup and bottling. Prepared pine needles are extracted with liquid carbon dioxide to separate corresponding miscella. Prepared chicory is cut and dried in microwave field to residual moisture content of about 20 % at microwave field power, providing warming of chicory inside bits to temperature 80-90 °C during at least 1 hour, roasted, impregnated with separated miscella with simultaneous pressure increase. Method then includes reducing pressure to atmospheric pressure value with simultaneous freezing of chicory, crushed and mashed in an amount of about 3.6 % of sugar consumption together with dry bread kvass.EFFECT: method reduces duration of process and increases foam stability of end product.1 cl
Spring, Lisa;Jaenicke, Martina;Marschner, Norbert;Steffens, Claus-Christoph;Elender, Corinna;Hutzschenreuter, Ulrich;Dille, Stephanie;Binninger, Adrian
来源期刊：Lung cancer: Journal of the International Association for the Study of Lung Cancer
Objectives: Despite intensive research, the therapeutic options in extensive-stage small cell lung cancer (SCLC) are still limited. Data from routine clinical practice, so-called "real-world data", are centrally important to assess and improve the standard of care. We present prospectively documented data on systemic first-, second- and third-line treatment, number of treatment lines and outcome parameters of patients treated by medical oncologists in Germany.
GRADL GABRIELE;SCHNELLE THOMAS;MUELLER TORSTEN;REICHLE CHRISTOPH
(WO200238567) The invention relates to a method for measuring the vitality of biological cells, without destroying the latter, in particular for determining apoptosis. According to said method, at least one cell is subjected to high-frequency alternating electric fields, in particular rotating fields and/or impedance test fields and at least one rotation measurement, one dielectrophoresis measurement and/or one impedance measurement is performed on the cell for at least one frequency range or for individual frequencies. At least one measurement parameter, which characterises the state of vitality of the cell, is determined from said measurements.